Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jevcampe
    Member
    • Apr 2013
    • 13

    #1

    Blastx similarity %

    Dear all,

    I have performed a blastx on my 30.000 contigs of my transcriptome.
    I want to keep only the contigs for which the sequence description (output of blast2go) is reliable. i often see papers in which people only use a e-value cut off or a bit score cut off. Using this, I still have contigs with hits with a similarity of 40% that are not removed. I'm convinced that this is insufficient to trust the sequence description and to continue with GO, KEGG pathways and any furhter downstream application.
    I would like to use a similarity cut off to reliable say that the contig is in fact the gene and related function of the blast results. Does anybody know what a good cut off value might be? Or how to proceed.
    I have yet to encounter a paper where people really adress the low similarity problem. If you would have any suggestions feel free to share.

    Cheers,
  • kurban910
    Member
    • Jul 2014
    • 58

    #2
    hello jevcampe,
    did u solve your problem? if u did, what is the cut off you chose for similarity?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2





      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification,...
      10-30-2026, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 07:59 AM
    0 responses
    13 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 11-05-2026, 09:25 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 11-03-2026, 11:54 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    169 views
    0 reactions
    Last Post SEQadmin2  
    Working...